Linking a 10-Year Atherosclerotic Cardiovascular Disease Risk Score to New Cardiovascular Events in Stages 0–3 of Cardiovascular–Kidney–Metabolic Syndrome: Insights from the China Health and Retirement Longitudinal Study (CHARLS) - Report - MDSpire
Advertisement
Linking a 10-Year Atherosclerotic Cardiovascular Disease Risk Score to New Cardiovascular Events in Stages 0–3 of Cardiovascular–Kidney–Metabolic Syndrome: Insights from the China Health and Retirement Longitudinal Study (CHARLS)
Linking a 10-Year Atherosclerotic Cardiovascular Disease Risk Score to New Cardiovascular Events
Overview
This study investigates the association between baseline and cumulative 10-year atherosclerotic cardiovascular disease (ASCVD) risk scores and incident cardiovascular events across stages 0–3 of cardiovascular-kidney-metabolic syndrome in a Chinese population. Utilizing data from the China Health and Retirement Longitudinal Study (CHARLS), the findings highlight the importance of dynamic risk assessment in predicting cardiovascular outcomes.
Background
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality, particularly in low- and middle-income countries like China. The integration of cardiovascular, kidney, and metabolic dysfunction into a unified framework, known as cardiovascular-kidney-metabolic (CKM) syndrome, emphasizes the need for effective risk assessment and early intervention strategies. Understanding the relationship between ASCVD risk scores and cardiovascular events is crucial for improving preventive measures in populations with high cardiometabolic risk.
Data Highlights
No numerical data available in the provided source material.
Key Findings
The study utilized data from the CHARLS, focusing on adults aged 45 and older.
Baseline and cumulative ASCVD10 year scores were evaluated for their association with incident cardiovascular events.
Advanced statistical techniques were employed, including k-means clustering and mediation analyses.
Findings are expected to inform targeted interventions for reducing CVD burden in populations with high metabolic disorders.
The study addresses a significant gap in understanding ASCVD risk in the context of CKM syndrome stages.
Clinical Implications
The results underscore the necessity of dynamic ASCVD risk assessment in clinical practice, particularly for individuals in the early stages of CKM syndrome. Healthcare professionals should consider integrating these risk scores into routine evaluations to enhance preventive strategies against cardiovascular events.
Conclusion
This study provides valuable insights into the relationship between ASCVD risk scores and cardiovascular outcomes, highlighting the importance of tailored risk assessment in managing cardiometabolic health. Further research is needed to explore the implications of these findings in diverse populations.
Damon B. Dixon, MD, at Phoenix Children’s Cardiology, is the author to this EndoText chapter. Dr. Dixon brings nationally recognized expertise in pediatric cardiovascular risk assessment and non?invasive vascular imaging.
